Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 7, 2014, Pages 1240-1247

  Vilar, Enric ^a,b   Boltiador, Capella ^a,c   Viljoen, Adie ^a   Machado, Ashwini ^a   Farrington, Ken ^a,b  

^a LISTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C; UREA; BIOLOGICAL MARKER; CST3 PROTEIN, HUMAN;

ADULT; ARTICLE; CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NONRENAL CLEARANCE; AGED; BIOLOGICAL MODEL; BLOOD; BODY SURFACE; BODY WATER; EXTRACELLULAR FLUID; KIDNEY; KIDNEY DISEASES; KINETICS; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RENAL REPLACEMENT THERAPY;

AGED; BIOLOGICAL MARKERS; BODY SURFACE AREA; BODY WATER; CYSTATIN C; EXTRACELLULAR FLUID; FEMALE; GLOMERULAR FILTRATION RATE; HEMODIAFILTRATION; HUMANS; KIDNEY; KIDNEY DISEASES; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS;

EID: 84923832870     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07510713     Document Type: Article

References (48)

1. Grubb A: Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 38[Suppl 1]: S20–S27, 1992
2. Grubb AO: Cystatin C—properties and use as diagnostic marker. Adv Clin Chem 35: 63–99, 2000
3. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36: 29–34, 2000
4. Tenstad O, Roald AB, Grubb A, Aukland K: Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56: 409–414, 1996
5. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serumcreatinine as a marker of kidney function: A metaanalysis. Am J Kidney Dis 40: 221–226, 2002
6. Vinge E, Lindergård B, Nilsson-Ehle P, Grubb A: Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 59: 587–592, 1999
7. Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J: Cystatin C—a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101: 875–881, 1998
8. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51: 395–406, 2008
9. Tangri N, Inker LA, Tighiouart H, Sorensen E, Menon V, Beck G, Shlipak M, Coresh J, Levey AS, Sarnak MJ: Filtrationmarkers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 23: 351–359, 2012
10. Hoek FJ, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level. Nephrol Dial Transplant 22: 1633–1638, 2007
11. Sjöström PA, Jones IL, Tidman MA: Cystatin C as a filtration marker—haemodialysis patients expose its strengths and limitations. Scand J Clin Lab Invest 69: 65–72, 2009
12. Mayeur N, Rostaing L, Nogier MB, Jaafar A, Cointault O, Kamar N, Conil JM, Fourcade O, Lavayssiere L: Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure. Crit Care 14: R115, 2010
13. Huang SH, Filler G, Lindsay RM: Residual renal function calculated from serum cystatin C measurements and knowledge of the weekly standard Kt/V urea. Perit Dial Int 32: 102–104, 2012
14. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Foraster A, Soler J, Galceran JM, Martinez-Castelao A; Online Hemodiafiltration Study Group from the Catalonian Society of Nephrology: Design and patient characteristics of ESHOL study, a Catalonian prospective randomized study. J Nephrol 24: 196–202, 2011
15. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K: Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: A comparative analysis. Clin J Am Soc Nephrol 4: 1944–1953, 2009
16. Yang Q, Li R, Zhong Z, Mao H, Fan J, Lin J, Yang X, Wang X, Li Z, Yu X: Is cystatin C a better marker than creatinine for evaluating residual renal function in patients on continuous ambulatory peritoneal dialysis? Nephrol Dial Transplant 26: 3358–3365, 2011
17. Krishnamurthy N, Arumugasamy K, Anand U, Anand CV, Aruna V, Venu G, Gayathri R: Effect of hemodialysis on circulating cystatin c levels in patients with end stage renal disease. Indian J Clin Biochem 25: 43–46, 2010
18. Park JS, Kim GH, Kang CM, Lee CH: Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med 25: 77–81, 2010
19. Al-Malki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM: Cystatin C levels in functionally anephric patients undergoing dialysis: The effect of different methods and intensities. Clin J Am Soc Nephrol 4: 1606–1610, 2009
20. Huang SH, Filler G, Yasin A, Lindsay RM: Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis. Clin J Am Soc Nephrol 6: 319–325, 2011
21. Sjöström P, Tidman M, Jones I: Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 65: 111–124, 2005
22. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K: Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24: 2502–2510, 2009
23. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48[Suppl 1]: S2–S90, 2006
24. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33: 27–39, 1980
25. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int 61: 655–667, 2002
26. Schmidt JJ, Hafer C, Clajus C, Hadem J, Beutel G, Schmidt BM, Kielstein JT: New high-cutoff dialyzer allows improved middle molecule clearance without an increase in albumin loss: A clinical crossover comparison in extended dialysis. Blood Purif 34: 246–252, 2012
27. Krieter D: Optimum sieving and biocompatibility profiles of the new high-flux dialysis membrane Purema H. Presented at the 23rd Annual Meeting of the International Society of Blood Purification, Rotterdam, The Netherlands, September 1, 2005
28. Meert N, Eloot S, Schepers E, Lemke HD, Dhondt A, Glorieux G, Van Landschoot M, Waterloos MA, Vanholder R: Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant 26: 2624–2630, 2011
29. Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G: Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl 80: 126–142, 2002
30. Chamney PW, Krämer M, Rode C, Kleinekofort W, Wizemann V: A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 61: 2250–2258, 2002
31. Tzamaloukas AH, Saddler MS, Murphy G, Morgan K, Goldman RS, Murata GH, Malhotra D: Volume of distribution and fractional clearance of urea in amputees on continuous ambulatory peritoneal dialysis. Perit Dial Int 14: 356–361, 1994
32. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M: Rapid evaluation of creatinine clearance. Lancet 1: 1133–1134, 1971
33. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S: Measurement of muscle mass in humans: Validity of the 24-hour urinary creatinine method. Am J Clin Nutr 37: 478–494, 1983
34. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J AmSocNephrol 7: 745–750, 1996
35. Stickle D, Cole B, Hock K, Hruska KA, Scott MG: Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem 44: 1334–1338, 1998
36. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, Christensson A: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 51: 1420–1431, 2005
37. Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H: Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218: 499–503, 1985
38. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson- Ehle P, Lindström V, Grubb A: Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40: 1921–1926, 1994
39. Simonsen O, Grubb A, Thysell H: The blood serumconcentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45: 97–101, 1985
40. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47: 312–318, 1995
41. Carter JL, Lane CE, Fan SL, Lamb EJ: Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: Comparison with 51Cr-EDTA clearance. Nephrol Dial Transplant 26: 3729–3732, 2011
42. Campo A, Lanfranco G, Gramaglia L, Goia F, Cottino R, Giusto V: Could plasma cystatin C be useful as a marker of hemodialysis low molecular weight proteins removal? Nephron Clin Pract 98: c79–c82, 2004
43. Lindström V, Grubb A, Alquist Hegbrant M, Christensson A: Different elimination patterns of beta-trace protein, beta2- microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest 68: 685–691, 2008
44. Tidman M, Sjöström P, Jones I: Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients. Nephrol Dial Transplant 23: 1072–1073, 2008
45. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, Wisniewski HM: Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 173: 423–432, 1997
46. Ghiso J, Saball E, Leoni J, Rostagno A, Frangione B: Binding of cystatin C to C4: The importance of sense-antisense peptides in their interaction. Proc Natl Acad Sci U S A 87: 1288–1291, 1990
47. Wallin H, Abrahamson M, Ekström U: Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes. J Biol Chem 288: 17019–17029, 2013
48. Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 261: 11282–11289, 1986